868526-78-7Relevant articles and documents
Use of structure-based drug design approaches to obtain novel anthranilic acid acyl carrier protein synthase inhibitors
Joseph-McCarthy, Diane,Parris, Kevin,Huang, Adrian,Failli, Amedeo,Quagliato, Dominick,Dushin, Elizabeth Glasfeld,Novikova, Elena,Severina, Elena,Tuckman, Margareta,Petersen, Peter J.,Dean, Charles,Fritz, Christian C.,Meshulam, Tova,DeCenzo, Maureen,Dick, Larry,McFadyen, Iain J.,Somers, William S.,Lovering, Frank,Gilbert, Adam M.
, p. 7960 - 7969 (2005)
Acyl carrier protein synthase (AcpS) catalyzes the transfer of the 4′-phosphopantetheinyl group from the coenzyme A to a serine residue in acyl carrier protein (ACP), thereby activating ACP, an important step in cell wall biosynthesis. The structure-based